Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
BLOG: If sitting is the new smoking, should apps have warnings like cigarette packages?
For most of us doctors, it’s the last thing we look at before bed and the first thing when we wake up: the screen of our smartphone or tablet.
'Do not hesitate to seek help’: Balancing business, patient care in private practice
Private practice rheumatologists face an increasing array of challenges as large, corporate and academic health systems become the norm for medical care, threatening to bump smaller entities aside.
Log in or Sign up for Free to view tailored content for your specialty!
Gut microbiome dictates DMARD response in RA; DMARDs partly restore microbiota diversity
Gut microbiota profiles in stool samples of patients with rheumatoid arthritis predicted their response to disease-modifying antirheumatic drugs, according to data in Rheumatology.
Short-term JAK inhibitor therapy does not significantly increase serious adverse events
Janus kinase inhibitor therapy in short durations did not significantly increase the risk for major adverse cardiovascular events or venous thromboembolism in patients with low cardiovascular risk profiles, according to a study.
SLE-DAS remission, low disease activity show promise as treat-to-target measures
Remission and low disease activity can discriminate between patients taking active drug vs. placebo in clinical trials and are linked to health-related quality of life, according to data in Arthritis Care & Research.
Hooked on Rheum with Nancy E. Lane, MD
Reflecting on my decision to forge a career path in medicine and rheumatology, there were a series of experiences that strongly influenced me.
BLOG: Pricing your transaction with regulatory restrictions in mind
A pressing question on the mind of any practice owner when selling his or her practice is “how much money will I get?”
Achieve financial wellness
The term “wellness” has become increasingly popular in the general public at large, and within the medical community specifically.
Drug costs and nocebo risks: Navigating the Humira ‘biosimilar boom’ 1 year later
A lot can change in a year. But has it?
Treating psoriasis with biologics does not negatively affect COVID antibody production
The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study.
-
Headline News
VIDEO: Surface attacks in health care will be a ‘source of constant vulnerability’
January 02, 20256 min watch -
Headline News
National Kidney Foundation consensus: Race-free eGFR may optimize decision-making
January 09, 20252 min read -
Headline News
Cannabis use, schizophrenia genetic predisposition both independently raise psychosis risk
January 06, 20252 min read
-
Headline News
VIDEO: Surface attacks in health care will be a ‘source of constant vulnerability’
January 02, 20256 min watch -
Headline News
National Kidney Foundation consensus: Race-free eGFR may optimize decision-making
January 09, 20252 min read -
Headline News
Cannabis use, schizophrenia genetic predisposition both independently raise psychosis risk
January 06, 20252 min read